Sign up
Log in
Breaking Down Addus HomeCare: 6 Analysts Share Their Views
Share
Listen to the news

During the last three months, 6 analysts shared their evaluations of Addus HomeCare (NASDAQ:ADUS), revealing diverse outlooks from bullish to bearish.

The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 0 6 0 0 0
Last 30D 0 1 0 0 0
1M Ago 0 2 0 0 0
2M Ago 0 1 0 0 0
3M Ago 0 2 0 0 0

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $141.0, a high estimate of $150.00, and a low estimate of $129.00. This current average represents a 0.82% decrease from the previous average price target of $142.17.

price target chart

Decoding Analyst Ratings: A Detailed Look

The standing of Addus HomeCare among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Tao Qiu Macquarie Raises Outperform $133.00 $129.00
Nicholas Jones JMP Securities Maintains Market Outperform $150.00 $150.00
Constantine Davides JMP Securities Maintains Market Outperform $150.00 $150.00
Scott Fidel Stephens & Co. Maintains Overweight $142.00 $142.00
Tao Qiu Macquarie Maintains Outperform $129.00 $129.00
Raj Kumar Stephens & Co. Lowers Overweight $142.00 $153.00

Key Insights:

  • Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Addus HomeCare. This information offers a snapshot of how analysts perceive the current state of the company.
  • Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Addus HomeCare compared to the broader market.
  • Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Addus HomeCare's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Addus HomeCare analyst ratings.

Unveiling the Story Behind Addus HomeCare

Addus HomeCare Corp is engaged in the provision of in-home personal care services. It operates through the segments such as Personal care segment, which is a key revenue driver, provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill and disabled. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and their families. Its Home health segment provides services that are primarily medical in nature to those individuals who may require assistance during an illness or after surgery.

Unraveling the Financial Story of Addus HomeCare

Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.

Revenue Growth: Over the 3M period, Addus HomeCare showcased positive performance, achieving a revenue growth rate of 20.29% as of 31 March, 2025. This reflects a substantial increase in the company's top-line earnings. As compared to competitors, the company surpassed expectations with a growth rate higher than the average among peers in the Health Care sector.

Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 6.29%, the company showcases strong profitability and effective cost control.

Return on Equity (ROE): The company's ROE is below industry benchmarks, signaling potential difficulties in efficiently using equity capital. With an ROE of 2.16%, the company may need to address challenges in generating satisfactory returns for shareholders.

Return on Assets (ROA): Addus HomeCare's ROA stands out, surpassing industry averages. With an impressive ROA of 1.51%, the company demonstrates effective utilization of assets and strong financial performance.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.25.

What Are Analyst Ratings?

Within the domain of banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their work involves attending company conference calls and meetings, researching company financial statements, and communicating with insiders to publish "analyst ratings" for stocks. Analysts typically assess and rate each stock once per quarter.

In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

Breaking: Wall Street's Next Big Mover

Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. Click here for urgent details.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.